跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MAR-ATORVASTATIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MAR-ATORVASTATIN
Authorized
STANDARD
MAR-ATORVASTATIN
marcan pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
ac39951190a19843
Company
marcan pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
ac39951190a19843
Drug Approval Canada Name
MAR-ATORVASTATIN
Product Name
MAR-ATORVASTATIN
Status
Marketed
Status Date
2018-10-05
Original Market Date
2018-10-05
Din
02454033
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:06.08
Atc Original
C10AA05 ATORVASTATIN
Atc Name
c 10 aa 05
Aig Number
0133055003
Company Name
marcan pharmaceuticals inc
Company Address
2 Gurdwara Rd., Suite 112, Ottawa, Ontario, Canada, K2E 1A2
Active Ingredients
ATORVASTATIN (ATORVASTATIN CALCIUM)
40 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
ac39951190a19843
Type
Standard
Back to Health Canada Approvals